3 studies found for:    "Idiopathic juxtafoveal retinal telangiectasia"
Show Display Options
Rank Status Study
1 Completed Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)
Condition: Type 2 Idiopathic Macular Telangiectasia
Intervention: Drug: Intravitreal injection ranibizumab
2 Completed Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia
Conditions: Retina;   Telangiectasis
Intervention: Drug: Intravitreal Injection of Bevacizumab (1.25 mg/0.05ml)
3 Unknown  Effect of Avastin in Juxtafoveal Telangiectasias
Condition: Telangiectasis
Interventions: Drug: Bevacizumab;   Procedure: Intravitreal injection of Bevacizumab

Indicates status has not been verified in more than two years